Washington, DC…The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: Today, the FDA held a meeting of the Vaccines and Related Biological Products Advisory Committee to discuss the Emergency Use Authorization (EUA) request from Janssen Biotech Inc. for its COVID-19 Vaccine for the prevention of COVID-19 in individuals 18 years of age and older. Meeting materials are available on the FDA’s webpage. An archived link to the meeting webcast can be found here. Today, the FDA added new devices to the device discontinuance list, including sterilization products and oxygen conservers. There are no updates to the
Hence then, the article about fda panel recommends johnson johnson s janssen biotech covid vaccine for eua was published today ( ) and is available onThepintree.net ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( FDA Panel Recommends Johnson & Johnson’s Janssen Biotech Covid Vaccine for EUA! )